In contrast, IgG3 to CSP was associated with an increased risk of clinical malaria (2.52 [1.07, 5.90]), while IgA and IgM antibodies against P. falciparum antigens were not associated with the risk of clinical malaria (Fig. 3). Here, IGHG3 is linked to malaria.